Format

Send to

Choose Destination
See comment in PubMed Commons below
Ann Pathol. 2010 Dec;30(6):439-47. doi: 10.1016/j.annpat.2010.10.005. Epub 2010 Nov 27.

[Interest of immunohistochemistry for the diagnosis of benign hepatocellular tumors].

[Article in French]

Author information

1
Hôpital Pellegrin, CHU de Bordeaux, France. paulette.bioulac-sage@chu-bordeaux.fr

Abstract

In this review, we focus on the interest of immunohistochemistry first, to differentiate the two types of benign hepatocellular nodules: focal nodular hyperplasia (FNH) and hepatocellular adenoma (HCA) and second, to recognize the different subtypes of HCA: HNF1α inactivated HCA, β-catenin activated HCA and inflammatory HCA. This pathomolecular classication followed the study of genotype/phenotype correlations which led to the identification of immunohistochemical data characteristic of each subgroup. Immunohistochemical characteristics described on resected specimen are suitable on biopies of these tumors, facilitating their diagnosis and therefore allowing a better management of the patients.

PMID:
21167430
DOI:
10.1016/j.annpat.2010.10.005
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Masson (France)
    Loading ...
    Support Center